Concepedia

Meredith Pelster

MP

8

Publications

1.1K

Citations

8

H-Index

2019

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Virginia Cancer Specialists

Tennessee Oncology

Sarah Cannon

Memorial Sloan Kettering Cancer Center

Meredith Pelster is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2019–2023

8

Publications

8

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated <i>KRAS</i> G12C

Rona Yaeger, Jared Weiss, Meredith Pelster et al. · New England Journal of Medicine · 2022 · 440 citations · Full text

Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study

Meredith Pelster, Stephen K. Gruschkus, Roland L. Bassett et al. · Journal of Clinical Oncology · 2020 · 284 citations · Full text

Adagrasib in Advanced Solid Tumors Harboring a<i>KRAS</i><sup><i>G12C</i></sup>Mutation

Tanios Bekaii‐Saab, Rona Yaeger, Alexander I. Spira et al. · Journal of Clinical Oncology · 2023 · 244 citations · Full text

Trial in progress: A phase 1, first-in-human, open-label, multicenter, dose-escalation and dose-expansion study of ASP3082 in patients with previously treated advanced solid tumors and KRAS G12D mutations.

Anthony W. Tolcher, Wungki Park, Judy S. Wang et al. · Journal of Clinical Oncology · 2023 · 32 citations

, , +20

KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRAS<sup>G12C</sup> mutation.

Shubham Pant, Rona Yaeger, Alexander I. Spira et al. · Journal of Clinical Oncology · 2023 · 30 citations

, , +16

Rows per page

1–5 of 8